Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Tuesday. The brokerage set a “buy” rating on the stock.

Mannatech Stock Up 1.5 %

MTEX stock opened at $7.75 on Tuesday. The firm’s fifty day simple moving average is $7.41 and its 200-day simple moving average is $7.69. The company has a market capitalization of $14.61 million, a P/E ratio of -8.71 and a beta of 1.17. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.17 and a quick ratio of 0.62. Mannatech has a 12 month low of $6.75 and a 12 month high of $10.81.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The firm had revenue of $27.74 million during the quarter.

Insider Activity at Mannatech

In related news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now directly owns 54,721 shares in the company, valued at approximately $424,087.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.